Without doubt, the CBD space has taken its spot at the top of the list for growth themes in 2019 and 2020, with many analysts expecting a 10x or 20x expansion in total sales over the next 2-3 years.
Three stocks that stand to benefit most from this phenomenal growth curve – and deserve some attention from investors – include: Arcadia Biosciences Inc (NASDAQ:RKDA), For The Earth Corp (OTCMKTS:FTEG), and Aphria Inc (OTCMKTS:APHA).
Arcadia Biosciences Inc (NASDAQ:RKDA) frames itself as an agricultural food ingredient company that develops and commercializes health and nutrition ingredient traits worldwide.
The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits. It also provides nutritional oils comprising gamma linolenic acid safflower oil to manufacturers of dietary and nutritional supplements, medical foods, dog food, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products.
In addition, the company has various programs under development comprising fiber resistant starch wheat, whole grain flour, and reduced gluten wheat programs. Arcadia Biosciences, Inc. has strategic collaborations with Dow AgroSciences and Ardent Mills LLC to develop and commercialize wheat varieties.
However, the company also recently announced that it is moving in the CBD space, which makes sense as a reaction to the thriving and accelerating growth rates forecast for the space over the next 8 quarters.
And the stock has been acting well over recent days, up something like 3% in that time. Shares of the stock have powered higher over the past month, rallying roughly 40% in that time on strong overall action.
Arcadia Biosciences Inc (NASDAQ:RKDA) managed to rope in revenues totaling $370K in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of -37.2%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($24.6M against $2.6M).
For The Earth Corp (OTCMKTS:FTEG) frames itself as an emerging integrated CBD producer and retailer in the United States.
The Company is in the process of establishing a vertical framework that will extend from cultivation to extraction and production to a strategic retail footprint that includes multiple locations in Las Vegas and New York featuring mall kiosks, vending machines, e-commerce, and full store locations serving both the human and pet CBD markets.
Two mall leases have been signed recently in Las Vegas, with another vending machine location secured in New York City. The Company plans to expand its New York vending machine penetration by the end of 2019.
In addition, the Company has begun early-stage work to establish a state-of-the-art CBD extraction and production facility in Eugene, OR.
The stock has been holding support and seeing some rising participation. The company recently announced the launch of its new line of premium pharmaceutical grade anti-aging Topical CBD Skin Care products under the brand designation “Clean Life”. According to that release, the line of products includes Day Cream, Night Cream, Eye Serum, Face Serum, and Face Mask, all infused with the Company’s full spectrum THC-free CBD oil.
In addition, the company also recently provided an update noting that it had launched a new website, was closing in on finalizing the acquisition of a CBD extraction facility, launching a distribution facility, and expanding its retail footprint for selling CBD through mall kiosks and vending machines.
FTEG hasn’t really reacted to the news, closing the past week of action pretty much where it started. It will be interesting to see if the stock is able to break higher in coming days. FTEG shares have been relatively flat over the past month of action, with very little net movement during that period.
For The Earth Corp (OTCMKTS:FTEG) generated sales of $161K, according to information released in the company’s most recent quarterly financial report. The company also has cash levels at $137K.
Aphria Inc (OTCMKTS:APHA) commands a market cap of $3.46B as a leading global cannabis company driven by “an unrelenting commitment to our people, product quality and innovation.”
Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market.
The Company’s portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. “Rooted in our founders’ multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.”
The company touts itself as one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. The company is truly powered by sunlight, allowing for the most natural growing conditions available. “We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.
The action hasn’t really heated up in the stock, with shares moving net sideways over the past week. Shares of the stock have powered higher over the past month, rallying roughly 3% in that time on strong overall action.
Aphria Inc (NYSE:APHA) pulled in sales of $21.7M in its last reported quarterly financials, representing top line growth of 154.8%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($184.8M against $108.6M).